Articles

A review of the book 'A Call to Action' by Pfizer CEO Dr. Hank McKinnell. This review focuses on the 10 action items McKinnell promulgates. Notwithstanding an Amazon.com review of the book written by Peter Rost -- Pfizer's whistleblowing head of endocrine care marketing unit -- in which McKinnell is described as making 'an impressive mea culpa,' this book is actually a mea non culpa! Find out why..

A panel of experts at a recent continuing medical education conference discussed issues relating to the compliance with the 2004 Updated ACCME Standards for Commercial Support: Standards to Ensure the Independence of CME.

This article reviews Cardinal Health's portfolio of brand security technologies.

Segmedica's methodology for delving 'behind the curtain' of verbal responses to reveal what truly motivates physicians.

Preliminary results from The Drug Risk Survey, which posed questions about the FDA's proposed Drug Watch program as well as the Drug Risk Advisory System proposed independently.

This article reviews Imedex's approach to developing CME programs.

This is the first article in a continuing series that will keep you up-to-date on Blog topics from a variety of pharma-related Blogs created by individuals as well as pharma companies.

Instead of fancy, expensive ads or PR campaigns, why don't pharma companies interview a few employees and let us hear directly from them?

This article reviews Medigent Thought Leader, a Web-based software suite designed to dramatically improve a pharma company's communications with Key Opinion Leaders.

This article summarizes a panel discussion at a recent Pharmaceutical Executive Annual Marketing Summit in Philadelphia.